Academic Journal
Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir
| Τίτλος: | Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir |
|---|---|
| Συγγραφείς: | Ankrom, Wendy, Sanchez, Rosa I., Yee, Ka Lai, Fan, Li, Mitra, Pranab, Wolford, Dennis, Triantafyllou, Ilias, Sterling, Laura M., Stoch, S. Aubrey, Iwamoto, Marian, Khalilieh, Sauzanne |
| Συνεισφορές: | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA |
| Πηγή: | Antimicrobial Agents and Chemotherapy ; volume 63, issue 5 ; ISSN 0066-4804 1098-6596 |
| Στοιχεία εκδότη: | American Society for Microbiology |
| Έτος έκδοσης: | 2019 |
| Περιγραφή: | Doravirine is a non-nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Due to the high prevalence of HIV-1 and hepatitis C virus (HCV) coinfection and coadministration of HIV-1 and HCV treatment, potential drug-drug interactions (DDIs) between doravirine and two HCV treatments were investigated in two phase 1 drug interaction trials in healthy participants. |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| DOI: | 10.1128/aac.02491-18 |
| DOI: | 10.1128/AAC.02491-18 |
| Διαθεσιμότητα: | https://doi.org/10.1128/aac.02491-18 https://journals.asm.org/doi/pdf/10.1128/AAC.02491-18 |
| Rights: | https://journals.asm.org/non-commercial-tdm-license |
| Αριθμός Καταχώρησης: | edsbas.67DBC838 |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://doi.org/10.1128/aac.02491-18# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.67DBC838 RelevancyScore: 883 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 883.215454101563 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Ankrom%2C+Wendy%22">Ankrom, Wendy</searchLink><br /><searchLink fieldCode="AR" term="%22Sanchez%2C+Rosa+I%2E%22">Sanchez, Rosa I.</searchLink><br /><searchLink fieldCode="AR" term="%22Yee%2C+Ka+Lai%22">Yee, Ka Lai</searchLink><br /><searchLink fieldCode="AR" term="%22Fan%2C+Li%22">Fan, Li</searchLink><br /><searchLink fieldCode="AR" term="%22Mitra%2C+Pranab%22">Mitra, Pranab</searchLink><br /><searchLink fieldCode="AR" term="%22Wolford%2C+Dennis%22">Wolford, Dennis</searchLink><br /><searchLink fieldCode="AR" term="%22Triantafyllou%2C+Ilias%22">Triantafyllou, Ilias</searchLink><br /><searchLink fieldCode="AR" term="%22Sterling%2C+Laura+M%2E%22">Sterling, Laura M.</searchLink><br /><searchLink fieldCode="AR" term="%22Stoch%2C+S%2E+Aubrey%22">Stoch, S. Aubrey</searchLink><br /><searchLink fieldCode="AR" term="%22Iwamoto%2C+Marian%22">Iwamoto, Marian</searchLink><br /><searchLink fieldCode="AR" term="%22Khalilieh%2C+Sauzanne%22">Khalilieh, Sauzanne</searchLink> – Name: Author Label: Contributors Group: Au Data: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA – Name: TitleSource Label: Source Group: Src Data: Antimicrobial Agents and Chemotherapy ; volume 63, issue 5 ; ISSN 0066-4804 1098-6596 – Name: Publisher Label: Publisher Information Group: PubInfo Data: American Society for Microbiology – Name: DatePubCY Label: Publication Year Group: Date Data: 2019 – Name: Abstract Label: Description Group: Ab Data: Doravirine is a non-nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Due to the high prevalence of HIV-1 and hepatitis C virus (HCV) coinfection and coadministration of HIV-1 and HCV treatment, potential drug-drug interactions (DDIs) between doravirine and two HCV treatments were investigated in two phase 1 drug interaction trials in healthy participants. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Language Label: Language Group: Lang Data: English – Name: DOI Label: DOI Group: ID Data: 10.1128/aac.02491-18 – Name: DOI Label: DOI Group: ID Data: 10.1128/AAC.02491-18 – Name: URL Label: Availability Group: URL Data: https://doi.org/10.1128/aac.02491-18<br />https://journals.asm.org/doi/pdf/10.1128/AAC.02491-18 – Name: Copyright Label: Rights Group: Cpyrght Data: https://journals.asm.org/non-commercial-tdm-license – Name: AN Label: Accession Number Group: ID Data: edsbas.67DBC838 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.67DBC838 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1128/aac.02491-18 Languages: – Text: English Titles: – TitleFull: Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ankrom, Wendy – PersonEntity: Name: NameFull: Sanchez, Rosa I. – PersonEntity: Name: NameFull: Yee, Ka Lai – PersonEntity: Name: NameFull: Fan, Li – PersonEntity: Name: NameFull: Mitra, Pranab – PersonEntity: Name: NameFull: Wolford, Dennis – PersonEntity: Name: NameFull: Triantafyllou, Ilias – PersonEntity: Name: NameFull: Sterling, Laura M. – PersonEntity: Name: NameFull: Stoch, S. Aubrey – PersonEntity: Name: NameFull: Iwamoto, Marian – PersonEntity: Name: NameFull: Khalilieh, Sauzanne – PersonEntity: Name: NameFull: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2019 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa Titles: – TitleFull: Antimicrobial Agents and Chemotherapy ; volume 63, issue 5 ; ISSN 0066-4804 1098-6596 Type: main |
| ResultId | 1 |